Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Fowsiyo Ahmed"'
Autor:
Hao Wang, Wei Hou, Aldeb Perera, Carlee Bettler, Jordan R. Beach, Xianzhong Ding, Jun Li, Mitchell F. Denning, Asha Dhanarajan, Scott J. Cotler, Cara Joyce, Jun Yin, Fowsiyo Ahmed, Lewis R. Roberts, Wei Qiu
Publikováno v:
Cell Reports, Vol 34, Iss 8, Pp 108765- (2021)
Summary: Hepatocellular carcinoma (HCC) remains one of the deadliest malignancies worldwide. One major obstacle to treatment is a lack of effective molecular-targeted therapies. In this study, we find that EphA2 expression and signaling are enriched
Externí odkaz:
https://doaj.org/article/5490c094d7e84abdba870ac14d82cd3c
Autor:
Anna-Lee Clarke-Brodber, Christopher P. Hartley, Fowsiyo Ahmed, Judith Jebastin Thangaiah, Christin Tiegs-Heiden, Catherine E. Hagen
Publikováno v:
Annals of diagnostic pathology. 60
Desmoid-type fibromatosis (desmoid tumors) which involve the pancreas is an infrequent diagnosis which clinically can mimic both neoplastic and non-neoplastic lesions of the pancreas. The cytologic features of loosely cohesive cytologically bland (my
Autor:
Essa A Mohamed, Nasra H Giama, Abubaker O Abdalla, Hassan M Shaleh, Abdul M Oseini, Hamdi A Ali, Fowsiyo Ahmed, Wesam Taha, Hager Ahmed Mohammed, Jessica Cvinar, Ibrahim A Waaeys, Hawa Ali, Loretta K Allotey, Abdiwahab O Ali, Safra A Mohamed, William S Harmsen, Eimad M Ahmmad, Numra A Bajwa, Mohamud D Afgarshe, Abdirashid M Shire, Joyce E Balls-Berry, Lewis R Roberts
Publikováno v:
World journal of gastroenterology. 28(35)
Chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are known risk factors for liver disease, cirrhosis and hepatocellular carcinoma (HCC). There is substantial global variation in HBV and HCV prevalence resulting in variations in
Autor:
Benyam D. Addissie, Lewis R. Roberts, Kristin C. Mara, Gregory J. Gores, Alina M. Allen, Fowsiyo Ahmed, Ju Dong Yang
Publikováno v:
Hepatobiliary Surg Nutr
Hepatology
Hepatology
Diabetes increases the risk of liver disease progression and cirrhosis development in patients with nonalcoholic steatohepatitis (NASH). The association between diabetes and the risk of hepatocellular carcinoma (HCC) in NASH patients with cirrhosis i